Skip to main content

Table 10 Relationship between psychophysiological health outcomes and smoking cessation at the 12- and 24-week follow-ups

From: Initial assessment of a novel smoking cessation program integrating app-based behavioral therapy and an electronic cigarette: results of a pilot study

Outcome

12-weeks

24-weeks

ß

Adjusted p

OR (95% CI)

ß

Adjusted p

OR (95% CI)

PSS-10

−0.27

0.020*

0.76 (0.63–0.89)

−0.21

0.038*

0.81 (0.69–0.94)

 CPD at t0

−0.14

0.039*

0.87 (0.77–0.96)

−0.10

0.093

0.90 (0.81–0.99)

 PSS-10 at t0

0.13

0.139

1.14 (0.99–1.33)

0.08

0.434

1.08 (0.93–1.26)

FFA

3.74

0.039*

41.90 (3.35–1098.01)

1.88

0.147

6.56 (0.83–67.54)

 CPD at t0

−0.16

0.023*

0.85 (0.75–0.94)

−0.11

0.061

0.90 (0.81–0.98)

 FFA at t0

−3.70

0.023*

0.02 (0.00–0.22)

−1.82

0.148

0.16 (0.02–1.17)

SEQ-12

0.15

0.006**

1.16 (1.08–1.27)

0.23

0.006**

1.26 (1.14–1.47)

 CPD at t0

−0.19

0.023*

0.83 (0.71–0.93)

−0.05

0.582

0.95 (0.80–1.11)

 SEQ-12 at t0

0.01

0.856

1.01 (0.93–1.11)

−0.04

0.584

0.96 (0.85–1.08)

L-1

0.56

0.039*

1.02 (1.18–2.86)

0.37

0.088

1.44 (1.04–2.14)

 CPD at t0

−0.16

0.023*

0.85 (0.75–0.94)

−0.11

0.061

0.89 (0.80–0.98)

 L-1 at t0

−0.48

0.078

0.62 (0.37–0.93)

−0.26

0.270

0.77 (0.51–1.11)

SF12 PH

0.19

0.417

1.21 (0.86–1.79)

0.50

0.064

1.65 (1.11–2.76)

 CPD at t0

−0.15

0.003**

0.86 (0.77–0.94)

−0.12

0.056

0.89 (0.80–0.98)

 SF12 PH at t0

−0.05

0.735

0.95 (0.70–1.29)

−0.24

0.286

0.79 (0.54–1.13)

SF12 MH

0.21

0.056

1.24 (1.00–1.35)

0.33

0.039*

1.39 (1.11–1.97)

 CPD at t0

−0.16

0.020*

0.85 (0.77–0.94)

−0.12

0.049*

0.88 (0.80–0.97)

 SF12 MH at t0

−0.07

0.549

0.93 (0.77–1.12)

−0.07

0.548

0.93 (0.76–1.13)

  1. t0 = Baseline; t3 = 12-week follow-up; t4 = 24-week follow-up; p-values were adjusted for multiple comparisons using the BH method to control the FDR
  2. *p < 0.05, **p < 0.01, ***p < 0.001
Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640